Literature DB >> 11339390

Laparoscopic orchidopexy in children.

P P Godbole1, A S Najmaldin.   

Abstract

BACKGROUND: Cryptorchidism is a common condition in boys. Approximately 20% of undescended testes are nonpalpable and may be located within the abdominal cavity. Given the potential of these gonads for malignant transformation and infertility, it is essential to determine the presence or absence of a nonpalpable testis.
METHODS: Radiologic imaging and open surgical exploration have proved to be unreliable. In the hands of experienced surgeons, laparoscopy has become the method of choice for evaluating the nonpalpable testis. RESULTS AND
CONCLUSION: An increasing number of surgeons are applying laparoscopy in the treatment of nonpalpable testes, and early results are encouraging. Both diagnostic and therapeutic laparoscopy necessitate operative skills. The exact advantages of laparoscopy over conventional surgery in orchidectomy and single- or two-stage orchidopexy need to be determined.

Entities:  

Mesh:

Year:  2001        PMID: 11339390     DOI: 10.1089/089277901750161719

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  3 in total

Review 1.  Laparoscopic retroperitoneal lymph node dissection for nonseminomatous testicular carcinoma.

Authors:  Stefan Corvin; Markus Kuczyk; Aristotelis Anastasiadis; Arnulf Stenzl
Journal:  World J Urol       Date:  2004-03-19       Impact factor: 4.226

2.  Umbilical only access laparoscopic pyeloplasty in children: Preliminary report.

Authors:  Rajendra B Nerli; Prasad V Magdum; Shridhar C Ghagane; Murigendra B Hiremath; Mallikarjuna Reddy
Journal:  Afr J Paediatr Surg       Date:  2016 Jan-Mar

3.  Testicular descent and fixation through a scrotal stria incision for the treatment of palpable cryptorchidism in children aged <3 years: 10-year experience with 1034 cases.

Authors:  Liu Chen; Wen-Hua Huang; Yun-Jin Wang; Qi-Liang Zhang; Chao-Ming Zhou; Xu Cui; Jian-Qin Zhang
Journal:  Asian J Androl       Date:  2020 Nov-Dec       Impact factor: 3.285

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.